Association between sleep apnea, sleep duration, and serum lipid profile in an urban, male, working population in Japan

Chest

Volumn 143, Issue 3, 2013, Pages 720-728

  Toyama, Yoshiro ^a   Chin, Kazuo ^b   Chihara, Yuichi ^a   Takegami, Misa ^c,d   Takahashi, Ken Ichi ^e   Sumi, Kensuke ^f   Nakamura, Takaya ^g   Nakayama Ashida, Yukiyo ^a   Minami, Itsunari ^a   Horita, Sachiko ^h   Oka, Yasunori ⁱ   Wakamura, Tomoko ^a   Fukuhara, Shun Ichi ^c   Mishima, Michiaki ^a   Kadotani, Hiroshi ^a  

^a GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e OTSU RED CROSS HOSPITAL   (Japan)

^f National Hospital Organization Minami Kyoto Hospital   (Japan)

^g KYOTO CITY HOSPITAL   (Japan)

^h Sonoda Women's University   (Japan)

ⁱ EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACTIGRAPH; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD OXYGEN TENSION; CHOLESTEROL BLOOD LEVEL; COMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; EMPLOYEE; HEALTH SURVEY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PULSE OXIMETRY; RESPIRATORY DISTURBANCE INDEX; RESPIRATORY TRACT PARAMETERS; SLEEP DISORDERED BREATHING; SLEEP TIME; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; WAIST HIP RATIO;

EID: 84874966632     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0338     Document Type: Article

References (50)

1. Somers VK, White DP, Amin R, et al American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; Amer- ican Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008; 118 (10): 1080-1111.
2. Ip MSM, Lam B, Ng MMT, Lam WK, Tsang KWT, Lam KSL. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002; 165 (5): 670-676.
3. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002; 165 (5): 677-682.
4. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004; 25 (9): 735-741.
5. Sasanabe R, Banno K, Otake K, et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res. 2006; 29 (5): 315-322.
6. Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res. 2005; 97 (7): 698-706.
7. Savransky V, Nanayakkara A, Li J, et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med. 2007; 175 (12): 1290-1297.
8. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest. 2007; 131 (5): 1387-1392.
9. Ip MSM, Lam KSL, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000; 118 (3): 580-586.
10. Newman AB, Nieto FJ, Guidry U, et al Sleep Heart Health Study Research Group. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 2001; 154 (1): 50-59.
11. Can M, Açikgöz, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest. 2006; 129 (2): 233- 237.
12. Börgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J. 2006; 27 (1): 121-127.
13. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med. 2007; 175 (2): 190-195.
14. Savransky V, Jun J, Li J, et al. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res. 2008; 103 (10): 1173-1180.
15. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS ONE. 2010; 5 (8): e12065.
16. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep. 2006; 29 (8): 1009-1014.
17. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006; 47 (5): 833-839.
18. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003; 163 (2): 205-209.
19. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003; 26 (2): 380-384.
20. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005; 165 (8): 863-867.
21. Choi KM, Lee JS, Park HS, Baik SH, Choi DS, Kim SM. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes (Lond). 2008; 32 (7): 1091-1097.
22. Hall MH, Muldoon MF, Jennings JR, Buysse DJ, Flory JD, Manuck SB. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep. 2008; 31 (5): 635-643.
23. Bjorvatn B, Sagen IM, Øyane N, et al. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res. 2007; 16 (1): 66-76.
24. Williams CJ, Hu FB, Patel SR, Mantzoros CS. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007; 30 (5): 1233-1240.
25. Kaneita Y, Uchiyama M, Yoshiike N, Ohida T. Associations of usual sleep duration with serum lipid and lipoprotein levels. Sleep. 2008; 31 (5): 645-652.
26. van den Berg JF, Miedema HME, Tulen JHM, et al. Long sleep duration is associated with serum cholesterol in the elderly: the Rotterdam Study. Psychosom Med. 2008; 70 (9): 1005-1011.
27. Katano S, Nakamura Y, Nakamura A et al. Relationship between sleep duration and clustering of metabolic syndrome diagnostic components. Diabetes, Metab Syndr Obes. 2011; 4 : 119-125
28. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008; 19 (6): 838-845.
29. Chin K, Oga T, Takahashi K, et al. Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan. Sleep. 2010; 33 (1): 89-95.
30. Nakayama-Ashida Y, Takegami M, Chin K, et al. Sleepdisordered breathing in the usual lifestyle setting as detected with home monitoring in a population of working men in Japan. Sleep. 2008; 31 (3): 419-425.
31. Teramoto T, Sasaki J, Ueshima H, et al Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb. 2007; 14 (4): 155-158.
32. Morgenthaler T, Alessi C, Friedman L, et al Standards of Practice Committee; American Academy of Sleep Medicine. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007; 30 (4): 519-529.
33. Collop NA, Anderson WM, Boehlecke B, et al Portable Monitoring Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med. 2007; 3 (7): 737-747.
34. Ministry of Health, Labor, and Welfare of Japan. Summary of the National Health and Nutrition Survey 2006 [in Japanese]. Ministry of Health, Labor, and Welfare of Japan website. 2008. http://www.mhlw.go.jp/houdou/2008/04/dl/h0430- 2k.pdf. Accessed October 19, 2012.
35. Durán J, Esnaola S, Rubio R, Iztueta Á. Obstructive sleep apnea-hypopnea and related clinical features in a populationbased sample of subjects aged 30 to 70 yr. Am J Resp Crit Care Med. 2001; 163 (3 pt 1): 685-689
36. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106 (25): 3143-3421.
37. Brunzell JD, Davidson M, Furberg CD, et al; Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2008; 51 (15): 1512-1524.
38. Sarwar N, Sandhu MS, Ricketts SL, et al Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010; 375 (9726): 1634-1639.
39. Phillips CL, Yee BJ, Marshall NS, Liu PY, Sullivan DR, Grunstein RR. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial. Am J Respir Crit Care Med. 2011; 184 (3): 355-361.
40. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011; 365 (24): 2277-2286.
41. Juhász J, Becker H, Cassel W, Rostig S, Peter JH. Proportional positive airway pressure: a new concept to treat obstructive sleep apnoea. Eur Respir J. 2001; 17 (3): 467-473.
42. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 2000; 43 (5): 533-549.
43. Iesato K, Tatsumi K, Saibara T, et al. Decreased lipoprotein lipase in obstructive sleep apnea syndrome. Circ J. 2007; 71 (8): 1293-1298.
44. Barceló A, Piérola J, de la Peña M, et al. Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea. Eur Respir J. 2011; 37 (6): 1418-1423.
45. Magkos F, Mittendorfer B. Gender differences in lipid metabolism and the effect of obesity. Obstet Gynecol Clin North Am. 2009; 36 (2): 245-265 ., vii.
46. Harada Y, Oga T, Chin K, et al. Effects of the presence of hypertension on the relationship between obstructive sleep apnoea and sleepiness. J Sleep Res. 2011; 20 (4): 538-543.
47. Harada Y, Oga T, Chin K, et al. Differences in relationships among sleep apnoea, glucose level, sleep duration and sleep iness between persons with and without type 2 diabetes. J Sleep Res. 2012; 21 (4): 410-418.
48. Ministry of Internal Affairs and Communications. 2006 Survey on Time Use and Leisure Activities. Japanese Ministry of Internal Affairs and Communications website. 2006. http://www. stat.go.jp/english/data/shakai/2006/pdf/jikan-a.pdf. Accessed October 19, 2012.
49. US Centers for Disease Control and Prevention (CDC). Short sleep duration among workers - United States, 2010. MMWR CDC Surveillance Summaries. 2012; 61 (16): 281-285.
50. Organisation for Economic Co-operation and Development (OECD). Society at a glance 2009: OECD social indicators. 2009 : 19-49. http://www.oecd-ilibrary. org/social-issues-migrationhealth/society-at-a-glance-2009-soc-glance-2008-en. Accessed October 2012.